{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T19:12:38Z","timestamp":1648667558823},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"30","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,7]]},"DOI":"10.1093\/eurheartj\/ehaa676","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:43:50Z","timestamp":1597279430000},"page":"2821-2825","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing management of atrial fibrillation: integrated care, blood pressure control, ablation, and left atrial appendix occlusion"],"prefix":"10.1093","volume":"41","author":[{"given":"Thomas F","family":"L\u00fcscher","sequence":"first","affiliation":[{"name":"Professor of Cardiology, Imperial College and Director of Research, Education & Development, Royal Brompton and Harefield Hospitals London, UK"},{"name":"Professor and Chairman, Center for Molecular Cardiology, University of Zurich, Switzerland"},{"name":"Editor-in-Chief, EHJ Editorial Office, Zurich Heart House, Hottingerstreet 14, 8032 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"2020081206165863600_ehaa676-B1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/eurheartj\/ehx731","article-title":"Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis","volume":"39","author":"Mahajan","year":"2018","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/eurheartj\/eht507","article-title":"Antihypertensive treatment and risk of atrial fibrillation: a nationwide study","volume":"35","author":"Marott","year":"2014","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B5","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa168","article-title":"Integrated care for atrial fibrillation: time for widespread use","volume":"41","author":"Linde","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B6","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehz234","article-title":"Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Troms\u00f8 Study","volume":"41","author":"Sharashova","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/eurheartj\/ehy877","article-title":"Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population","volume":"40","author":"Kim","year":"2019","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B8","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1093\/eurheartj\/ehy287","article-title":"Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120\u2013140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials","volume":"39","author":"B\u00f6hm","year":"2018","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B9","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/eurheartj\/ehaa132","article-title":"Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial","volume":"41","author":"B\u00f6hm","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/eurheartj\/ehy801","article-title":"Reconsidering the cut-off diastolic blood pressure for predicting cardiovascular events: a nationwide population-based study from Korea","volume":"40","author":"Choi","year":"2019","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B11","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa247","article-title":"Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial","volume":"41","author":"B\u00f6hm","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B12","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa319","article-title":"Blood pressure targets in atrial fibrillation","volume":"41","author":"Shantsila","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2020081206165863600_ehaa676-B14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehz085","article-title":"Atrial fibrillation ablation in practice: assessing CABANA generalizability","volume":"40","author":"Noseworthy","year":"2019","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B15","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1093\/eurheartj\/ehy452","article-title":"Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014","volume":"39","author":"Steinbeck","year":"2018","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B16","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz443","article-title":"Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data","volume":"41","author":"Chen","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B17","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz704","article-title":"With our powers combined: Does the pooled analysis of existing randomized data regarding treatment of atrial fibrillation in heart failure settle the case for catheter ablation?","volume":"41","author":"Honarbakhsh","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B18","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1093\/eurheartj\/ehx490","article-title":"The definition of the Brugada syndrome","volume":"38","author":"Sieira","year":"2017","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B19","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa383","article-title":"An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins","volume":"41","author":"Chatterjee","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B20","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehy412","article-title":"SCN5A mutations in 442 neonates and children: genotype\u2013phenotype correlation and identification of higher-risk subgroups","volume":"39","author":"Baruteau","year":"2018","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B21","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa468","article-title":"A highly specific biomarker for Brugada syndrome. Also too good to be true?","volume":"41","author":"Wilde","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B22","first-page":"869","article-title":"Left atrial appendage occlusion: rationale, evidence, devices, and patient selection","volume":"38","author":"Piccini","year":"2017","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B23","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer\u2122 Amulet\u2122 device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B24","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa261","article-title":"Rebellious palpitations","volume":"41","author":"Holmes","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B25","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz907","article-title":"Somatic mosaicism: implications for the cardiovascular system","volume":"41","author":"Sano","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B26","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa263","article-title":"Narrow or broad QRS tachycardia: does 120 ms matter?","volume":"41","author":"B\u0142aszyk","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B27","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC)","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B28","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa470","article-title":"Identifying coronary artery disease patients at risk for sudden and\/or arrhythmic death: remaining limitations of the electrocardiogram","volume":"41","author":"Asatryan","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B29","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1093\/eurheartj\/ehaa177","article-title":"Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease","volume":"41","author":"Chatterjee","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B30","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa472","article-title":"The electrocardiogram and sudden death: capturing electrical physiology and arrhythmic substrate","volume":"41","author":"Chatterjee","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B31","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa264","article-title":"Machine learning-based mortality prediction: how to be connected to daily clinical practice?","volume":"41","author":"Kim","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B32","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/eurheartj\/ehz902","article-title":"Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score","volume":"41","author":"Tokodi","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B33","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa449","article-title":"The ongoing quest for improving machine learning-based risk stratification","volume":"41","author":"Tokodi","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B34","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa179","article-title":"Febuxostat and atrial fibrillation","volume":"41","author":"Kuwabara","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B35","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa297","article-title":"Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants","volume":"41","author":"Sugiyama","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/eurheartj\/ehz952","article-title":"Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study","volume":"41","author":"Huang","year":"2020","journal-title":"Eur Heart J"},{"key":"2020081206165863600_ehaa676-B37","article-title":"Hip fracture risk in patients with atrial fibrillation receiving oral anticoagulants: a meta-analysis based on current observational studies","volume":"41","author":"Huang","year":"2020","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/30\/2821\/33643401\/ehaa676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/41\/30\/2821\/33643401\/ehaa676.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:43:57Z","timestamp":1597279437000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/41\/30\/2821\/5891312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":37,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2020,8,11]]},"published-print":{"date-parts":[[2020,8,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaa676","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8,7]]},"published":{"date-parts":[[2020,8,7]]}}}